Evogene(EVGN)

0.6722 0.0221 3.3995%

今开:0.682昨收:0.6501
最高:0.6876 最低:0.6416
涨停价:0.0跌停价:0.0
总市值:3.4028967E7

Evogene的最新讨论

Takeabreak2021-12-31 14:34

$Evogene(EVGN)$ Added @1.68 Last adding was 2.6查看全文

Takeabreak2021-09-01 08:40

$Evogene(EVGN)$ 准备续写$阿米瑞斯(AMRS)$ 的故事(走势)??
Pre launch of medical cannabis. 网页链接查看全文

Takeabreak2021-04-20 23:15

$Evogene(EVGN)$ 4/21 investor day. 先high起来, 现在就是4刀时的 $阿米瑞斯(AMRS)$
$Compugen医疗(CGEN)$查看全文

Takeabreak2021-03-11 12:33

$Affimed(AFMD)$ We will see $10 in a few weeks, maybe 15-20, who knows.
Quote:
AFM13 is also being evaluated in combination with cord-blood derived natural killer cells in CD30-positive lymphomas at MD Anderson Cancer Center (MDACC). Initial data from this investiga...查看全文

Takeabreak2021-03-09 11:59

$Evogene(EVGN)$ 没有跟跌,貌似能够稳住!下4再小加,等到跌停止了,也有一些仓位了,心里舒服了,再好好买(磨)。半(1,2)年后,向上就有一定仓位了! 参考AMRS,喜欢看准了通过左侧重仓,右侧不会做技不如人查看全文

Takeabreak2021-03-06 01:06

$工艺酿酒联盟(HOOK)$ 今天你太亮了,BIO持仓中最靓的仔。跌幅最大的是$Evogene(EVGN)$ 还有$Kala制药(KALA)$ MDNA.......查看全文

Takeabreak2021-03-05 22:53

$Evogene(EVGN)$ 继续 -10%+, 就想问你服不服?查看全文

1 2 3

Evogene的新闻

融资丨「Biomica」完成新一轮融资,上海生物医药基金与Evogene联合投资

本轮募集资金将主要用于:完成肿瘤免疫项目BMC128的一期临床研究,并推进到二期临床试验;完成并扩大针对炎症性肠病(IBD)的BMC333项目的GMP生产,并为BMC333的一期临床试验进行准备工作;以及推进其他研发计划。 以色... 网页链接

Evogene的公告

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001182  Act: 34  Size: 46 KB 网页链接

生效批准

$Evogene(EVGN)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000766  Act: 33  Size: 1 KB 网页链接

招股说明书

$Evogene(EVGN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001178913-24-001152  Act: 33  Size: 899 KB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001150  Act: 34  Size: 283 KB 网页链接

年度财报

$Evogene(EVGN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-24-001137  Act: 34  Size: 19 MB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000995  Act: 34  Size: 32 KB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000857  Act: 34  Size: 476 KB 网页链接

增发股票注册声明

$Evogene(EVGN)$ F-3 Registration statement by foreign private issuers Accession Number: 0001178913-24-000782  Act: 33  Size: 1 MB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000687  Act: 34  Size: 36 KB 网页链接

财报披露

$Evogene(EVGN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-000670  Act: 34  Size: 36 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30